ACC 2018Acute Coronary SyndromeConferences ODYSSEY Outcomes: Alirocumab Reduces CV Outcomes and All-Cause Mortality in ACS Patients Sadaf Sharfaei Share 0 Min Read Dr. Schwartz and Dr. Gibson Discuss Subscribe on iTunes or Google Play. TAGGED:ACC 2018ConferenceFeatured Share This Article Copy Link Print Leave a Comment Leave a Reply Cancel replyYou must be logged in to post a comment.
